ALB and neoplasm: TNFR1 knockout reduced tumor incidence significantly, from 78% in DDB1F/F, Alb-Cre+/− mouse to 31% in DDB1F/F, Alb-Cre+/−, TNFR1−/− mouse (Figure 7A, 7B).